As a negative control, diffuse large B cell lymphoma (DLBCL) blood was shown to contain almost no CD45+/CD19+/CD235a+ cells (Figure 4B; Supplementary Figure 12B), possibly because no tumor cells were available in peripheral blood at the time of sample collection. This evidence concerns the gene CD19 and diffuse large B-cell lymphoma.